TASHKENT, Uzbekistan, June 28. The Chamber of
Commerce and Industry of Uzbekistan and Pakistan鈥檚 Glitz Group have
reached an agreement to establish a joint venture in Uzbekistan
focused on the production of high value-added pharmaceutical
products and their export to regional markets, Trend reports.
The agreement followed a meeting between Deputy Chairman of the
Chamber, Dilshod Rasulov, and Chaudhry Bilal, Director of Glitz
Group鈥攐ne of Pakistan鈥檚 leading international investment and
pharmaceutical holdings.
During the talks, the parties discussed prospects for bilateral
cooperation in the pharmaceutical, nutraceutical, and cosmeceutical
Bilal praised Uzbekistan鈥檚 rapidly growing pharmaceutical
industry, highlighting the country鈥檚 favorable investment climate,
ongoing reforms, and government support for foreign investors. He
expressed strong interest in expanding Glitz Group鈥檚 manufacturing
footprint to Uzbekistan.
In response, Rasulov endorsed the initiative and affirmed the
Chamber鈥檚 preparedness to extend comprehensive support,
encompassing facilitation of project schematics, navigation of
compliance frameworks, and establishing synergies with credible
local stakeholders.
The convening signified a pivotal advancement in the enhancement of
bilateral synergies between Uzbekistan and Pakistan within the
realms of cutting-edge technology and export-driven sectors.
Glitz Group boasts a robust portfolio of over 650 certified
offerings across its flagship brands, including Glitz Pharma, Glitz
Life Care, and Glitzderm, while strategically penetrating
international markets in over 20 countries. The organization鈥檚
manufacturing protocols adhere to ISO and cGMP benchmarks and are
accredited by the Drug Regulatory Authority of Pakistan (DRAP).
Stay up-to-date with more news on Trend News
Agency’s WhatsApp channel